Glen Eagle Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-53
Closed -$2.45K 1109
2024
Q4
$2.45K Hold
53
﹤0.01% 847
2024
Q3
$2.51K Hold
53
﹤0.01% 874
2024
Q2
$2.26K Hold
53
﹤0.01% 878
2024
Q1
$2.36K Buy
+53
New +$2.42K ﹤0.01% 885
2023
Q3
Sell
-54
Closed -$2.57K 1065
2023
Q2
$2.57K Hold
54
﹤0.01% 838
2023
Q1
$2.62K Hold
54
﹤0.01% 817
2022
Q4
$2.84K Hold
54
﹤0.01% 819
2022
Q3
$2.35K Hold
54
﹤0.01% 836
2022
Q2
$2.69K Hold
54
﹤0.01% 791
2022
Q1
$2.79K Hold
54
﹤0.01% 770
2021
Q4
$3.17K Hold
54
﹤0.01% 760
2021
Q3
$2.95K Hold
54
﹤0.01% 877
2021
Q2
$2.76K Hold
54
﹤0.01% 883
2021
Q1
$2.77K Hold
54
﹤0.01% 850
2020
Q4
$3.01K Hold
54
﹤0.01% 808
2020
Q3
$2.98K Hold
54
﹤0.01% 757
2020
Q2
$2.44K Hold
54
﹤0.01% 744
2020
Q1
$2.37K Hold
54
﹤0.01% 699
2019
Q4
$1.93K Hold
54
﹤0.01% 783
2019
Q3
$1.88K Hold
54
﹤0.01% 707
2019
Q2
$2.31K Hold
54
﹤0.01% 690
2019
Q1
$2.32K Hold
54
﹤0.01% 642
2018
Q4
$1.96K Hold
54
﹤0.01% 630
2018
Q3
$2.16K Hold
54
﹤0.01% 627
2018
Q2
$2.06K Hold
54
﹤0.01% 608
2018
Q1
$1.84K Hold
54
﹤0.01% 597
2017
Q4
$1.76K Hold
54
﹤0.01% 578
2017
Q3
$1.8K Buy
+54
New +$1.86K ﹤0.01% 587

Other funds holding QGEN

Glen Eagle Advisors's QGEN Position: Q1 2025 in Review

Glen Eagle Advisors sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 53 shares — an estimated $2.45K sold.

Glen Eagle Advisors first reported a position in QGEN in Q3 2017 and held it in 28 quarters. The position peaked at $3.17K in Q4 2021. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

  • Glen Eagle Advisors reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 53 Qiagen shares in Q1 2025, an estimated $2.45K.
  • Glen Eagle Advisors first reported a position in Qiagen in Q3 2017 and held it in 28 quarters.
  • Glen Eagle Advisors's Qiagen position peaked at $3.17K in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Glen Eagle Advisors's 13F filing for Q1 2025, filed 15 May 2025.